Beyond HD, correction of splicing deficits and consequent increases in the level of SMN2 in mouse models of spinal muscular atrophy improves hepatic phenotypes and greatly extends survival compared to treatments limited to the CNS [36]. Here, SMN2 is linked to proximal spinal muscular atrophy.